545
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Preparation of a novel liver-targeting nanoparticle of norcantharidin derivative and evaluation of its anti-tumour activity

, , , , , , , , & show all
Pages 183-199 | Received 24 Feb 2009, Accepted 19 Apr 2010, Published online: 26 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Catherine C. Applegate, Hongping Deng, Brittany L. Kleszynski, Tzu-Wen L. Cross, Christian J. Konopka, L. Wawrzyniec Dobrucki, Erik R. Nelson, Matthew A. Wallig, Andrew M. Smith & Kelly S. Swanson. (2022) Impact of administration route on nanocarrier biodistribution in a murine colitis model. Journal of Experimental Nanoscience 17:1, pages 599-616.
Read now
Yan Shen, Yun Xia, Ershuang Yang, Zixuan Ye, Yuan Ding, Jiasheng Tu, Yong Zhang & Pengcheng Xu. (2020) A polyoxyethylene sorbitan oleate modified hollow gold nanoparticle system to escape macrophage phagocytosis designed for triple combination lung cancer therapy via LDL-R mediated endocytosis. Drug Delivery 27:1, pages 1342-1359.
Read now
Yong-Yan Bei, Zhi-Qiang Yuan, Liang Zhang, Xiao-Feng Zhou, Wei-Liang Chen, Peng Xia, Yang Liu, Ben-Gang You, Xiao-Juan Hu, Qiao-Ling Zhu, Chun-Ge Zhang, Xue-Nong Zhang & Yong Jin. (2014) Novel self-assembled micelles based on palmitoyl-trimethyl-chitosan for efficient delivery of harmine to liver cancer. Expert Opinion on Drug Delivery 11:6, pages 843-854.
Read now
Yong-Yan Bei, Xiao-Feng Zhou, Ben-Gang You, Zhi-Qiang Yuan, Wei-Liang Chen, Peng Xia, Yang Liu, Yong Jin, Xiao-Juan Hu, Qiao-Ling Zhu, Chun-Ge Zhang, Xue-Nong Zhang & Liang Zhang. (2013) Application of the central composite design to optimize the preparation of novel micelles of harmine. International Journal of Nanomedicine 8, pages 1795-1808.
Read now
Min Guan, Qiao-Ling Zhu, Yang Liu, Yong-Yan Bei, Zong-Lin Gu, Xue-Nong Zhang & Qiang Zhang. (2012) Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers. International Journal of Nanomedicine 7, pages 1921-1930.
Read now

Articles from other publishers (6)

Farid Mostafaei, Salar Hemmati, Hadi Valizadeh, Mohammad Mahmoudian, Muhammad Sarfraz, Mahdieh Abdi, Shukoofeh Torabi, Behzad Baradaran, Massoud Vosough & Parvin Zakeri-Milani. (2024) Enhanced intracellular accumulation and cytotoxicity of bortezomib against liver cancer cells using N-stearyl lactobionamide surface modified solid lipid nanoparticles. International Journal of Pharmaceutics 649, pages 123635.
Crossref
Peng Liu, Heng Li, Ruiyi Li, Yan Geng, Jinsong Gong, Hongyu Xu, Zhenghong Xu & Jinsong Shi. (2022) Nanoencapsulation of chitooligosaccharides enhances its oral bioavailability and anti-liver fibrotic effects. Food Research International 157, pages 111471.
Crossref
Maria Cristina Bonferoni, Elisabetta Gavini, Giovanna Rassu, Marcello Maestri & Paolo Giunchedi. (2020) Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting. Nanomaterials 10:5, pages 870.
Crossref
Sabyasachi Maiti. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy 429 454 .
Rong Zhu, Chun-ge Zhang, Yang Liu, Zhi-qiang Yuan, Wei-liang Chen, Shu-di Yang, Ji-zhao Li, Wen-jing Zhu, Xiao-feng Zhou, Ben-gang You & Xue-nong Zhang. (2015) CD147 monoclonal antibody mediated by chitosan nanoparticles loaded with α-hederin enhances antineoplastic activity and cellular uptake in liver cancer cells. Scientific Reports 5:1.
Crossref
Min Guan, Yi Zhou, Qiao-Ling Zhu, Yang Liu, Yong-Yan Bei, Xue-Nong Zhang & Qiang Zhang. (2012) N-trimethyl chitosan nanoparticle-encapsulated lactosyl-norcantharidin for liver cancer therapy with high targeting efficacy. Nanomedicine: Nanotechnology, Biology and Medicine 8:7, pages 1172-1181.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.